ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Imatinib mesylate induced erythroderma: A rare case report

Journal: IP Indian Journal of Clinical and Experimental Dermatology (IJCED) (Vol.3, No. 2)

Publication Date:

Authors : ; ;

Page : 88-90

Keywords : Imatinib mesylate; Adverse cutaneous drug reaction; Erythroderma;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe adverse reactions are seen in 5% of patients. Exfoliative dermatitis has been very rarely reported with this drug. We report a case of a 55-year-old female who initially presented with a maculopapular rash and developed erythroderma on continuation of the drug.

Last modified: 2017-07-13 17:54:45